1-7 of 7
Brendan D. Curti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 736: Deep learning response score using baseline and 12-week RECIST chest CTs enhances overall survival (OS) prediction in advanced NSCLC: external validation in a trial with dostarlimab

Free
Brenda F. Kurland, Chiharu Sako, Jing He, Marius de Groot, Taly G. Schmidt, Arpan A. Patel, Dwight H. Owen, Arya Amini, Brendan D. Curti, Ronan J. Kelly, Ray D. Page, Aurelie Swalduz, Jean-Paul Beregi, Jan Chrusciel, Stephane Sanchez, Richard Rosenberg, Jakob Weiss, An Liu, Olivier Gevaert, George R. Simon, Ravi B. Parikh, Alma Hart, Petr Jordan, Jasper van der Aart
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 736.
https://doi.org/10.1158/1538-7445.AM2025-736
Published: 21 April 2025
View articletitled, Abstract 736: Deep learning response score using baseline and 12-week RECIST chest CTs enhances overall survival (OS) prediction in advanced NSCLC: external validation in a trial with dostarlimab
Journal Articles

Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors

Free
Jason J. Luke, Melissa Johnson, Anthony Tolcher, Christopher T. Chen, Tong Dai, Brendan D. Curti, Anthony El-Khoueiry, Mario Sznol, Brian S. Henick, Christine Horak, Pushpa Jayaraman, Christopher B. Cole, Dawn Wilson, Lizhi Cao, Li Peng, David Feltquate, Deanne Lathers, Manish R. Sharma
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT034.
https://doi.org/10.1158/1538-7445.AM2023-CT034
Published: 14 April 2023
View articletitled, Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors
Journal Articles

Abstract 5618: Multi-institutional validation of a radiomics-based artificial intelligence method for predicting response to PD-1/PD-L1 immune checkpoint inhibitor (ICI) therapy in stage IV NSCLC

Free
Ravi B. Parikh, Petr Jordan, Rita J. Ciaravino, Ryan A. Beasley, Arpan A. Patel, Dwight H. Owen, Arya Amini, Brendan D. Curti, Ray Page, Aurelie Swalduz, Jean-Paul Beregi, Jan Chrusciel, Eric Snyder, Pritam Mukherjee, Heather M. Selby, Soohee Lee, Roshanthi Weerasinghe, Shwetha Pindikuri, Jakob B. Weiss, Andrew L. Wentland, Anish Kirpalani, An Liu, Olivier Gevaert, George Simon, Hugo JWL Aerts
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5618.
https://doi.org/10.1158/1538-7445.AM2023-5618
Published: 04 April 2023
View articletitled, Abstract 5618: Multi-institutional validation of a radiomics-based artificial intelligence method for predicting response to PD-1/PD-L1 immune checkpoint inhibitor (ICI) therapy in stage IV NSCLC
Journal Articles

Abstract LB180: Clinical biomarker studies with two fusion-enhanced versions of oncolytic HSV (RP1 and RP2) alone and in combination with nivolumab in cancer patients indicate potent immune activation

Free
Kevin J. Harrington, Francesca Aroldi, Joseph J. Sacco, Mohammed M. Milhem, Brendan D. Curti, Ari M. Vanderwalde, Scott Baum, Adel Samson, Anna C. Pavlick, Jason A. Chesney, Jiaxin Niu, Terence D. Rhodes, Tawnya L. Bowles, Robert Conry, Anna Olsson-Brown, Douglas E. Laux, Pablo Nenclares, Lavita Menezes, Alex Deterding, Victoria Roulstone, Joan Kyula, Suzanne Thomas, Praveen K. Bommareddy, Selda Samakoglu, Andrea Pirzkall, Robert S. Coffin, Mark R. Middleton
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB180.
https://doi.org/10.1158/1538-7445.AM2021-LB180
Published: 01 July 2021
View articletitled, Abstract LB180: Clinical biomarker studies with two fusion-enhanced versions of oncolytic HSV (RP1 and RP2) alone and in combination with nivolumab in cancer patients indicate potent immune activation
Journal Articles

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab

Free
Yoshinobu Koguchi, Helena M. Hoen, Shelly A. Bambina, Michael D. Rynning, Richard K. Fuerstenberg, Brendan D. Curti, Walter J. Urba, Christina Milburn, Frances Rena Bahjat, Alan J. Korman, Keith S. Bahjat
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (23): 5084–5092.
https://doi.org/10.1158/0008-5472.CAN-15-2303
Published: 30 November 2015
View articletitled, Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab
Open the PDF for Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab in another window
Includes: Supplementary data
Journal Articles

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Free
Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, Edwin Walker, Lana Chisholm, Kevin Floyd, Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen, Bernard A. Fox, Tarsem Moudgil, William Miller, Daniel Haley, Todd Coffey, Brenda Fisher, Laurie Delanty-Miller, Nicole Rymarchyk, Tracy Kelly, Todd Crocenzi, Eric Bernstein, Rachel Sanborn, Walter J. Urba, Andrew D. Weinberg
Journal: Cancer Research
Cancer Res (2013) 73 (24): 7189–7198.
https://doi.org/10.1158/0008-5472.CAN-12-4174
Published: 16 December 2013
View articletitled, OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
Open the PDF for OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Interstitial Pressure of Subcutaneous Nodules in Melanoma and Lymphoma Patients: Changes during Treatment

Free
Brendan D. Curti, Walter J. Urba, W. Gregory Alvord, John E. Janik, John W. Smith, II, Karen Madara, Dan L. Longo
Journal: Cancer Research
Cancer Res (1993) 53 (10): 2204–2207.
Published: 01 May 1993
View articletitled, Interstitial Pressure of Subcutaneous Nodules in Melanoma and Lymphoma Patients: Changes during Treatment
Open the PDF for Interstitial Pressure of Subcutaneous Nodules in Melanoma and Lymphoma Patients: Changes during Treatment in another window